Financials SynBiotic SE Xetra

Equities

SBX

DE000A3E5A59

Pharmaceuticals

Real-time Estimate Tradegate 06:43:11 24/06/2024 pm IST 5-day change 1st Jan Change
7.59 EUR +2.57% Intraday chart for SynBiotic SE -10.07% +154.24%

Valuation

Fiscal Period: December 2019 2020 2021 2022
Capitalization 1 - 47.7 97.53 37.92
Enterprise Value (EV) 1 - 42.02 97.74 41.08
P/E ratio -26.1 x -37.6 x -7.04 x -1.73 x
Yield - - - -
Capitalization / Revenue - 87,59,024 x 1,07,60,271 x 46,43,328 x
EV / Revenue - 77,16,840 x 1,07,83,962 x 50,31,340 x
EV / EBITDA - -5,75,00,876 x -2,02,19,743 x -52,79,310 x
EV / FCF - 82,34,048 x -73,96,645 x -1,02,73,083 x
FCF Yield - 0% -0% -0%
Price to Book 1.48 x 1.3 x 3.07 x 2.06 x
Nbr of stocks (in thousands) - 2,250 3,340 3,674
Reference price 2 1.400 21.20 29.20 10.32
Announcement Date 21/06/21 21/06/21 28/10/22 21/08/23
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022
Net sales - 5.446 9.064 8.166
EBITDA - -0.7308 -4.834 -7.782
EBIT 1 -0.0134 -0.8507 -5.579 -9.136
Operating Margin - -15.62% -61.55% -111.88%
Earnings before Tax (EBT) 1 -0.0134 -0.8588 -13.36 -26.19
Net income 1 -0.0134 -0.8804 -12.72 -24.36
Net margin - -16.17% -140.39% -298.35%
EPS 2 -0.0537 -0.5638 -4.150 -5.970
Free Cash Flow - 5.104 -13.21 -3.999
FCF margin - 93.72% -145.8% -48.98%
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 21/06/21 21/06/21 28/10/22 21/08/23
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022
Net Debt 1 - - 0.21 3.17
Net Cash position 1 0.01 5.68 - -
Leverage (Debt/EBITDA) - - -0.0444 x -0.4071 x
Free Cash Flow - 5.1 -13.2 -4
ROE (net income / shareholders' equity) -5.54% -6.84% -42% -87.4%
ROA (Net income/ Total Assets) -3.44% -3.02% -7.29% -11.3%
Assets 1 0.3903 29.2 174.6 216
Book Value Per Share 2 0.9400 16.30 9.530 5.000
Cash Flow per Share 2 0.0500 3.840 0.8700 0.2100
Capex - 0.02 0.37 0.28
Capex / Sales - 0.33% 4.03% 3.41%
Announcement Date 21/06/21 21/06/21 28/10/22 21/08/23
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise